Search

everythinglearnresearchcommunity

for

Search:↓

αMSH may help regulate immune responses in hair follicles and its disruption could lead to hair loss.

EPI-NCSCs from hair follicles may help treat brain development issues in mice.

Progesterone significantly reduces neuroblastoma tumor growth without harming healthy cells.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

ILC1-like cells may contribute to hair loss in alopecia areata.

Microneedling may help treat some autoimmune skin conditions, but more research is needed.

Certain mice without specific receptors or mast cells don't lose hair from stress.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

5α-reduced neurosteroids may help regulate glial cell differentiation.

Increasing TSPO in the brain may help improve memory problems.

Isoflavones from soy may help manage multiple sclerosis symptoms, but more research is needed.

Hair follicle and adipose cell vesicles both protect neurons and reduce inflammation similarly.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Immune cells are crucial for hair growth and preventing hair loss.

Vitamin D affects many body functions and its interaction with microRNAs could help treat related diseases.

Euph E and Euri A from Euphorbia neriifolia help control inflammation and immune response in cells.

Early changes in brain chemicals affect how a drug reduces alcohol intake in rats.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

Early neurosteroid changes can alter adult brain function and behavior.

Targeting Midkine can help reduce pain and itching in keloids.

Standardizing light therapy methods could improve spinal cord injury treatment.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

miR-21 helps improve ovarian function recovery in treated mice.